Published online before print March 30, 2001, doi: 10.1161/hh0701.088842
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2001 American Heart Association, Inc.
Online First Article |
Ischemic Preconditioning Upregulates Vascular Endothelial Growth Factor mRNA Expression and Neovascularization via Nuclear Translocation of Protein Kinase C 
in the Rat Ischemic Myocardium
From the First Department of Internal Medicine (H. Kawata, A.K., H. Kurioka, E.T., Y.S., T.H., K.D.), Nara Medical University, Nara; Department of Forensic Medicine (K.-i.Y., K.H., M.K.), Graduate School of Medicine, University of Tokyo; and Department of Anatomy and Cell Biology (T.U.), Wakayama Medical College, Wakayama, Japan.
Correspondence to Ken-ichi Yoshida, MD, Department of Forensic Medicine, Graduate School of Medicine, University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. E-mail kyoshida{at}m-u.tokyo.ac.jp
Abstract
Abstract—Ischemic
preconditioning (IP) exerts cardioprotection through protein kinase C
(PKC) activation, whereas myocardial ischemia enhances vascular
endothelial growth factor (VEGF) mRNA expression.
However, the IP effect or the involvement of PKC on the VEGF expression
is unknown in myocardial infarction. We investigated whether IP
enhances VEGF gene expression and angiogenesis through PKC activation
in the in vivo myocardial infarction model. Sprague-Dawley rats were
assigned into the following 3 groups: the sham group; the IP group,
which underwent 3 cycles of 3 minutes of ischemia and 5 minutes
of reperfusion (IP procedure); and the non-IP group. The latter 2
groups were subsequently subjected to left anterior descending
coronary artery occlusion. To examine the involvement of PKC,
the PKC inhibitor chelerythrine (5 mg/kg) or
bisindolylmaleimide (1 mg/kg) was injected intravenously
before the IP procedures. PKC
was translocated to the nucleus after
10 minutes of ischemia after the IP procedure but was not
translocated in the non-IP and the sham groups. VEGF mRNA expression 3
hours after infarction was significantly higher in the IP group than in
the non-IP and the sham groups. Capillary density in the infarction was
significantly higher, whereas the infarct size was smaller in the IP
group than in the non-IP group at 3 days of infarction. Chelerythrine
but not bisindolylmaleimide blocked all of the IP effects on the
nuclear translocation of PKC, enhancement of VEGF mRNA expression
and angiogenesis, and infarct size limitation. These results
show that IP may enhance VEGF gene expression and angiogenesis through
nuclear translocation of PKC in the infarcted
myocardium.
Key Words: angiogenesis • ischemic preconditioning • myocardial infarction • protein kinase C • vascular endothelial growth factor
This article has been cited by other articles:
 |
|
 |
|
  D. J. Hausenloy and D. M. Yellon Cardioprotective growth factors Cardiovasc Res, July 15, 2009; 83(2): 179 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kamota, T.-S. Li, N. Morikage, M. Murakami, M. Ohshima, M. Kubo, T. Kobayashi, A. Mikamo, Y. Ikeda, M. Matsuzaki, et al. Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase. J. Am. Coll. Cardiol., May 12, 2009; 53(19): 1814 - 1822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Czibik, Z. Wu, G. P. Berne, M. Tarkka, J. Vaage, J. Laurikka, O. Jarvinen, and G. Valen Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia-inducible factor 1 alpha in the heart Eur. J. Cardiothorac. Surg., November 1, 2008; 34(5): 976 - 984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Xu, P. Czerwinski, M. Hortmann, H.-Y. Sohn, U. Forstermann, and H. Li Protein kinase C {alpha} promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor Cardiovasc Res, May 1, 2008; 78(2): 349 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Chen, A. K. S. Camara, D. F. Stowe, C. L. Hoppel, and E. J. Lesnefsky Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion Am J Physiol Cell Physiol, January 1, 2007; 292(1): C137 - C147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Wang, D. Weihrauch, D. A. Schwabe, M. Bienengraeber, D. C. Warltier, J. R. Kersten, P. F. Pratt Jr, and P. S. Pagel Extracellular signal-regulated kinases trigger isoflurane preconditioning concomitant with upregulation of hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in rats. Anesth. Analg., August 1, 2006; 103(2): 281 - 8, table of contents. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dhein New, emerging roles for cardiac connexins. Mitochondrial Cx43 raises new questions Cardiovasc Res, August 1, 2005; 67(2): 179 - 181. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ii, H. Nishimura, A. Iwakura, A. Wecker, E. Eaton, T. Asahara, and D. W. Losordo Endothelial Progenitor Cells Are Rapidly Recruited to Myocardium and Mediate Protective Effect of Ischemic Preconditioning via "Imported" Nitric Oxide Synthase Activity Circulation, March 8, 2005; 111(9): 1114 - 1120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Date, S. Mochizuki, A. J. Belanger, M. Yamakawa, Z. Luo, K. A. Vincent, S. H. Cheng, R. J. Gregory, and C. Jiang Expression of constitutively stable hybrid hypoxia-inducible factor-1{alpha} protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury Am J Physiol Cell Physiol, February 1, 2005; 288(2): C314 - C320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Mizukami, A. Iwamatsu, T. Aki, M. Kimura, K. Nakamura, T. Nao, T. Okusa, M. Matsuzaki, K.-i. Yoshida, and S. Kobayashi ERK1/2 Regulates Intracellular ATP Levels through {alpha}-Enolase Expression in Cardiomyocytes Exposed to Ischemic Hypoxia and Reoxygenation J. Biol. Chem., November 26, 2004; 279(48): 50120 - 50131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Morimoto, Y. Kurahashi, K. Shintani-Ishida, N. Kawamura, M. Miyashita, M. Uji, N. Tan, and K.-i. Yoshida Estrogen replacement suppresses stress-induced cardiovascular responses in ovariectomized rats Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1950 - H1956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Das, R. Ockaili, F. Salloum, and R. C. Kukreja Protein kinase C plays an essential role in sildenafil-induced cardioprotection in rabbits Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1455 - H1460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Z. Simkhovich, P. Marjoram, C. Poizat, L. Kedes, and R. A. Kloner Brief episode of ischemia activates protective genetic program in rat heart: a gene chip study Cardiovasc Res, August 1, 2003; 59(2): 450 - 459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Singh and H. K. Saini Resident Cardiac Mast Cells and Ischemia-Reperfusion Injury Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2003; 8(2): 135 - 148. [Abstract] [PDF]
|
|
|
|
|
|
A. M. Gardner and M. E. Olah Distinct Protein Kinase C Isoforms Mediate Regulation of Vascular Endothelial Growth Factor Expression by A2A Adenosine Receptor Activation and Phorbol Esters in Pheochromocytoma PC12 Cells J. Biol. Chem., April 18, 2003; 278(17): 15421 - 15428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Lankford, A. M. Byford, K. J. Ashton, B. A. French, J. K. Lee, J. P. Headrick, and G. P. Matherne Gene expression profile of mouse myocardium with transgenic overexpression of A1 adenosine receptors Physiol Genomics, October 29, 2002; 11(2): 81 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wolfrum, K. Schneider, M. Heidbreder, J. Nienstedt, P. Dominiak, and A. Dendorfer Remote preconditioning protects the heart by activating myocardial PKC{epsilon}-isoform Cardiovasc Res, August 15, 2002; 55(3): 583 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Baines, J. Zhang, G.-W. Wang, Y.-T. Zheng, J. X. Xiu, E. M. Cardwell, R. Bolli, and P. Ping Mitochondrial PKC{epsilon} and MAPK Form Signaling Modules in the Murine Heart: Enhanced Mitochondrial PKC{epsilon}-MAPK Interactions and Differential MAPK Activation in PKC{epsilon}-Induced Cardioprotection Circ. Res., March 8, 2002; 90(4): 390 - 397. [Abstract] [Full Text] [PDF]
|
|